TTEN·K/calls
Pinned
  • The Brief
  • Congress
  • Screener
  • Markets
  • The Brief
  • Signal Confluence
  • The Flip Side
  • Markets
  • Calendar
  • Coverage
  • Screener
  • Discover
  • Smart Money
  • Congress
  • Insiders
  • IPOs
  • 13F Funds
  • Events
  • Filings
  • News
  • Trending
  • Groups
  • Data catalog
  • Research
  • Education
  • Options Plays
  • Options Calculator
  • Leaderboards
  • Compare
  • Portfolio
  • Strategies
  • Track
  • Pricing
  • API
  • Newsletter
  • Follow the calls
  • Feedback
  • Account
Go ProUpgrade →
TTEN·K/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Telegram ↗X ↗Bluesky ↗Follow the calls →

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

MethodologyDisclosuresTermsPrivacy

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

Intraday
NVDA$210.96▲4.03%AAPL$315.32▼0.28%GOOGL$357.18▼0.48%GOOG$355.03▼0.34%MSFT$385.10▲0.19%AMZN$245.34▼0.69%TSM$434.11▼0.65%SPCX$145.30▼4.51%AVGO$399.97▼0.28%META$669.21▲5.97%TSLA$407.76▲0.30%MU$979.30▼1.24%LLY$1,188.58▼2.33%BRK-B$493.71▼0.35%BRK-A$739,750.00▼0.17%JPM$336.47▲0.30%WMT$113.90▲1.51%AMD$557.89▲2.04%ASML$1,797.32▼0.38%V$348.97▲0.22%JNJ$256.98▼0.82%XOM$138.88▲1.03%INTC$109.84▼2.40%AMAT$602.50▲2.35%CSCO$121.31▲2.54%MA$526.74▲0.68%LRCX$350.33▼0.80%ABBV$248.08▼0.73%CAT$952.41▲1.49%BAC$59.67▲0.71%
NVDA$210.96▲4.03%AAPL$315.32▼0.28%GOOGL$357.18▼0.48%GOOG$355.03▼0.34%MSFT$385.10▲0.19%AMZN$245.34▼0.69%TSM$434.11▼0.65%SPCX$145.30▼4.51%AVGO$399.97▼0.28%META$669.21▲5.97%TSLA$407.76▲0.30%MU$979.30▼1.24%LLY$1,188.58▼2.33%BRK-B$493.71▼0.35%BRK-A$739,750.00▼0.17%JPM$336.47▲0.30%WMT$113.90▲1.51%AMD$557.89▲2.04%ASML$1,797.32▼0.38%V$348.97▲0.22%JNJ$256.98▼0.82%XOM$138.88▲1.03%INTC$109.84▼2.40%AMAT$602.50▲2.35%CSCO$121.31▲2.54%MA$526.74▲0.68%LRCX$350.33▼0.80%ABBV$248.08▼0.73%CAT$952.41▲1.49%BAC$59.67▲0.71%
Home›Compare›HUM vs CNC
Head-to-head · SEC filings only

Humana vs Centene: which stock is the better buy?

Our verdict

On the filings, Humana (HUM) is the stronger stock right now — higher on our blended fundamentals-plus-verdict read, and we currently rate it HOLD.

HUM: 59/100CNC: 45/100blended fundamentals + verdict
HUMHumanaHold

Top line grows 10% but earnings power has cratered for four straight years — a trough-margin recovery bet, not a clean buy.

Revenue (FY2025) $130B · FY2025
Is HUM a buy? →
CNCCenteneHold

Nation's largest Medicaid/Marketplace insurer hit a real profitability air pocket — cheap and cash-generative, but policy fog clouds the rebound.

Revenue (FY2025) $175B · FY2025
Is CNC a buy? →

The numbers, from the filings

MetricHUMCNC
Fundamentals score5838
Revenue growth (YoY)+10.1%+20.0%
Net income growth (YoY)-1.6%-301.9%
Net margin0.9%-3.8%
Return on equity6.7%-33.4%
ROIC (est.)7.1%-16.1%
Liabilities / Equity1.772.84
Piotroski F-score5 / 94 / 9

Bold green = the stronger figure. All rows derive from SEC XBRL filings — no market-price data on this page.

Common questions

Humana or Centene — which stock is better?
On the filings, Humana (HUM) is the stronger stock right now — higher on our blended fundamentals-plus-verdict read, and we currently rate it HOLD. This comparison uses SEC-filing data only: fundamentals scores, revenue and income growth, margins, returns on capital and balance-sheet health.
Is HUM (Humana) a buy?
Our current verdict on Humana is HOLD (conviction 3/5), re-evaluated nightly against its SEC filings. The one-page verdict has the reasoning.
Is CNC (Centene) a buy?
Our current verdict on Centene is HOLD (conviction 3/5), re-evaluated nightly against its SEC filings. The one-page verdict has the reasoning.
What data is this comparison based on?
Everything here derives from SEC EDGAR XBRL filings: growth, margins, returns and health ratios, plus our filings-only fundamentals scores and buy/hold/sell verdicts. We deliberately exclude market-price data, so the comparison reflects the businesses, not the tape.

More head-to-heads

  • NVDA vs AMD
  • V vs MA
  • AMZN vs GOOGL
  • KO vs PEP
  • UBER vs LYFT
  • HD vs LOW
  • UPS vs FDX
  • XOM vs CVX
  • Build your own →
›About this recommendation — produced by TENK/calls (tenkcalls.com), Luxembourg · not investment advice

AI-generated analysis, produced by our proprietary engine from SEC filing data.

Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 21, 2026, 12:24 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.

›About this recommendation — produced by TENK/calls (tenkcalls.com), Luxembourg · not investment advice

AI-generated analysis, produced by our proprietary engine from SEC filing data.

Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 29, 2026, 8:39 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Intraday
NVDA$210.96▲4.03%AAPL$315.32▼0.28%GOOGL$357.18▼0.48%GOOG$355.03▼0.34%MSFT$385.10▲0.19%AMZN$245.34▼0.69%TSM$434.11▼0.65%SPCX$145.30▼4.51%AVGO$399.97▼0.28%META$669.21▲5.97%TSLA$407.76▲0.30%MU$979.30▼1.24%LLY$1,188.58▼2.33%BRK-B$493.71▼0.35%BRK-A$739,750.00▼0.17%JPM$336.47▲0.30%WMT$113.90▲1.51%AMD$557.89▲2.04%ASML$1,797.32▼0.38%V$348.97▲0.22%JNJ$256.98▼0.82%XOM$138.88▲1.03%INTC$109.84▼2.40%AMAT$602.50▲2.35%CSCO$121.31▲2.54%MA$526.74▲0.68%LRCX$350.33▼0.80%ABBV$248.08▼0.73%CAT$952.41▲1.49%BAC$59.67▲0.71%
NVDA$210.96▲4.03%AAPL$315.32▼0.28%GOOGL$357.18▼0.48%GOOG$355.03▼0.34%MSFT$385.10▲0.19%AMZN$245.34▼0.69%TSM$434.11▼0.65%SPCX$145.30▼4.51%AVGO$399.97▼0.28%META$669.21▲5.97%TSLA$407.76▲0.30%MU$979.30▼1.24%LLY$1,188.58▼2.33%BRK-B$493.71▼0.35%BRK-A$739,750.00▼0.17%JPM$336.47▲0.30%WMT$113.90▲1.51%AMD$557.89▲2.04%ASML$1,797.32▼0.38%V$348.97▲0.22%JNJ$256.98▼0.82%XOM$138.88▲1.03%INTC$109.84▼2.40%AMAT$602.50▲2.35%CSCO$121.31▲2.54%MA$526.74▲0.68%LRCX$350.33▼0.80%ABBV$248.08▼0.73%CAT$952.41▲1.49%BAC$59.67▲0.71%
Intraday
NVDA$210.96▲4.03%AAPL$315.32▼0.28%GOOGL$357.18▼0.48%GOOG$355.03▼0.34%MSFT$385.10▲0.19%AMZN$245.34▼0.69%TSM$434.11▼0.65%SPCX$145.30▼4.51%AVGO$399.97▼0.28%META$669.21▲5.97%TSLA$407.76▲0.30%MU$979.30▼1.24%LLY$1,188.58▼2.33%BRK-B$493.71▼0.35%BRK-A$739,750.00▼0.17%JPM$336.47▲0.30%WMT$113.90▲1.51%AMD$557.89▲2.04%ASML$1,797.32▼0.38%V$348.97▲0.22%JNJ$256.98▼0.82%XOM$138.88▲1.03%INTC$109.84▼2.40%AMAT$602.50▲2.35%CSCO$121.31▲2.54%MA$526.74▲0.68%LRCX$350.33▼0.80%ABBV$248.08▼0.73%CAT$952.41▲1.49%BAC$59.67▲0.71%
NVDA$210.96▲4.03%AAPL$315.32▼0.28%GOOGL$357.18▼0.48%GOOG$355.03▼0.34%MSFT$385.10▲0.19%AMZN$245.34▼0.69%TSM$434.11▼0.65%SPCX$145.30▼4.51%AVGO$399.97▼0.28%META$669.21▲5.97%TSLA$407.76▲0.30%MU$979.30▼1.24%LLY$1,188.58▼2.33%BRK-B$493.71▼0.35%BRK-A$739,750.00▼0.17%JPM$336.47▲0.30%WMT$113.90▲1.51%AMD$557.89▲2.04%ASML$1,797.32▼0.38%V$348.97▲0.22%JNJ$256.98▼0.82%XOM$138.88▲1.03%INTC$109.84▼2.40%AMAT$602.50▲2.35%CSCO$121.31▲2.54%MA$526.74▲0.68%LRCX$350.33▼0.80%ABBV$248.08▼0.73%CAT$952.41▲1.49%BAC$59.67▲0.71%